超声内镜引导下使用腔壁贴合金属支架联合或不联合同轴塑料支架引流包裹性坏死性胰腺炎:前瞻性双中心随机对照试验
这项前瞻性双中心随机对照试验将67例包裹性坏死性胰腺炎患者随机分为LAMS联合DPS组(A组,n=34)和单用LAMS组(B组,n=33),比较索引方法失败率、不良事件率和死亡率。A组总体不良事件率显著低于B组(20.7% vs 51.5%,P=.008),支架阻塞率也显著更低(14.7% vs 36.3%,P=.042);索引方法失败率(29.4% vs 48.5%,P=.109)和带支架死亡率(2.9% vs 12.1%,P=.197)数值上较低但未达统计学显著。
要点
- LAMS联合DPS组总体不良事件率显著低于单用LAMS组(20.7% vs 51.5%,P=.008)。
- 支架阻塞率在联合DPS组显著更低(14.7% vs 36.3%,P=.042)。
- 索引方法失败率与带支架死亡率两组间未达统计学显著差异。
核心结论
- 在超声内镜引导下引流包裹性坏死性胰腺炎时,LAMS内追加同轴DPS与显著更低的总体不良事件率和支架阻塞率相关。
研究设计与样本
- 前瞻性双中心随机对照试验,连续纳入有引流指征的包裹性坏死性胰腺炎患者,随机分为LAMS联合DPS组(A组,n=34)和单用LAMS组(B组,n=33)。
- 所有LAMS计划在索引操作后3周移除,移除前先行CT决定是否需要额外步骤(如经腔坏死组织清除术或对WON未完全缓解者放置经腔塑料支架)。
- 主要结局为索引方法失败(定义为LAMS移除前因LAMS相关不良事件和/或临床恶化需要再次干预)、不良事件率和带LAMS死亡率。
- 统计采用Mann-Whitney U检验、χ2检验或Fisher精确检验,P<.05为显著。
主要发现
- 共67例患者(女性37.3%;平均年龄54±14.4岁)在2个三级中心接受LAMS置入,其中联合DPS 34例、未联合DPS 33例。
- 两组基线特征(人口学、病因、合并症、无菌性与感染性坏死)可比;LAMS和DPS置入技术成功率均为100%。
- A组总体不良事件率显著低于B组(20.7% vs 51.5%,P=.008)。
- 支架阻塞是最常见的不良事件,A组显著低于B组(14.7% vs 36.3%,P=.042)。
- 索引方法失败率A组低于B组(29.4% vs 48.5%,P=.109),但差异未达统计学显著;带LAMS死亡率同样为A组2.9% vs B组12.1%(P=.197),未达统计学显著。
关键数值与推荐
- 总体不良事件率:A组20.7% vs B组51.5%(P=.008)。
- 支架阻塞率:A组14.7% vs B组36.3%(P=.042)。
- 索引方法失败率:A组29.4% vs B组48.5%(P=.109),未达统计学显著。
- 带LAMS死亡率:A组2.9% vs B组12.1%(P=.197),未达统计学显著。
- LAMS和DPS置入技术成功率均为100%。
临床怎么用
- 作者结论认为,在超声内镜引导下引流包裹性坏死性胰腺炎时,LAMS内追加同轴DPS与显著更低的总体不良事件率和支架阻塞率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Lumen-apposing metal stents (LAMSs) have proven to be effective for drainage of pancreatic walled-off necrosis (WON), although associated adverse events (AEs) have been reported. Anchoring coaxial double-pigtail plastic stents (DPSs) within LAMSs have been proposed to prevent LAMS-related AEs but have not been assessed in prospective studies. We aimed to evaluate the utility of such measures with a randomized controlled trial. METHODS: We randomly assigned consecutive patients with WON indications for drainage to EUS-guided transluminal drainage using LAMSs with (group A) or without (group B) DPSs. All LAMSs were to be removed after 3 weeks had elapsed from the index procedure with a preceding CT to decide whether additional steps needed to be taken (eg, transluminal necrosectomy or placing transluminal plastic stents in patients with incomplete resolution of WON). The main outcomes were failure of the index method, defined as necessity of reintervention (endoscopic, percutaneous, or surgical) before LAMS removal because of LAMS-related AEs and/or clinical deterioration; AE rates; and mortality with the LAMS in place. Variables were evaluated using the Mann-Whitney U test, χ2 test, or Fisher exact test as appropriate. P < .05 was considered significant. RESULTS: Sixty-seven patients (37.3% women; mean age, 54 ± 14.4 years) underwent LAMS placement with (n = 34) or without (n = 33) DPS placement in 2 tertiary centers. Baseline characteristics including demographics, etiology, comorbidity, and clinical presentation (sterile vs infected necrosis) were comparable between both groups. The technical success rate in placing LAMSs and DPSs was 100%. The global rate of AEs was significantly lower in group A versus group B (20.7% vs 51.5%, respectively; P = .008). Stent occlusion was the most frequently observed AE (14.7% vs 36.3%, P = .042). Failure of the index method was lower in group A versus group B (29.4% vs 48.5%, respectively; P = .109); however, the difference did not achieve statistical significance. The same applied to the mortality rate with LAMSs in place (2.9% vs 12.1%, P = .197). CONCLUSIONS: The addition of a coaxial DPS within a LAMS was associated with a significantly lower global rate of AEs and stent occlusion rate in EUS-guided drainage of WON. (Clinical trial registration number: NCT03923686.).
引用
- Vanek P, Falt P, Vitek P, et al. EUS-guided transluminal drainage using lumen-apposing metal stents with or without coaxial plastic stents for treatment of walled-off necrotizing pancreatitis: a prospective bicentric randomized controlled trial. Gastrointest Endosc. 2023. PMID: 36646148. doi:10.1016/j.gie.2022.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。